CELYAD ONCOLOGY SA Adjustments For Depreciation Expense
CELYAD ONCOLOGY SA reported Adjustments For Depreciation Expense of EUR 144.00 thousand for the 6-month period ending 2023-06-30, per its 6-K filed 2023-09-05.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForDepreciationExpense · last filed 2023-09-05
| Period end | Adjustments For Depreciation Expense 6 month | Adjustments For Depreciation Expense 12 month |
|---|---|---|
| 2023-06-30 | 144.00K EUR 6-K · filed 2023-09-05 | |
| 2022-12-31 | 827.00K EUR 20-F · filed 2023-03-23 | |
| 2022-06-30 | 516.00K EUR 6-K · filed 2023-09-05 | |
| 2021-12-31 | 1.30M EUR 20-F · filed 2023-03-23 | |
| 2021-06-30 | 735.00K EUR 6-K · filed 2022-08-05 | |
| 2020-12-31 | 1.64M EUR 20-F · filed 2023-03-23 | |
| 2020-06-30 | 792.00K EUR 6-K · filed 2021-08-04 | |
| 2019-12-31 | 1.62M EUR 20-F · filed 2022-03-24 | |
| 2019-06-30 | 802.00K EUR 6-K · filed 2020-08-07 | |
| 2018-12-31 | 1.05M EUR 20-F · filed 2021-03-24 | |
| 2018-06-30 | 606.00K EUR 6-K/A · filed 2019-09-05 | |
| 2017-12-31 | 966.00K EUR 20-F · filed 2020-03-25 | |
| 2016-12-31 | 760.00K EUR 20-F · filed 2019-04-05 | |
| 2015-12-31 | 273.00K EUR 20-F · filed 2018-04-06 |